NCT05131191 is a clinical trial of CT-FFR measurement in Coronary Stent Occlusion, sponsored by Beijing Hospital.

Who is sponsoring NCT05131191?

NCT05131191 is sponsored by Beijing Hospital.

What drugs are being tested in NCT05131191?

Interventions in NCT05131191: CT-FFR measurement, invasive FFR.

What condition does NCT05131191 study?

NCT05131191 studies Coronary Stent Occlusion.

Is NCT05131191 still recruiting?

NCT05131191 is currently status unknown. Last updated 8 February 2023.

Last reviewed 2023-02-08 · How we verify

NCT05131191

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CT-FFR for Coronary In-stent Stenosis Based on ISR-Net Algorithm

Status unknown Last updated 8 February 2023

What this trial tests

trial testing CT-FFR measurement in Coronary Stent Occlusion in 150 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 January 2024

1 June 2024

Quick facts

Lead sponsor	Beijing Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 January 2022
Primary completion	1 January 2024
Estimated completion	1 June 2024
Sites	1 location across China

Drugs / interventions tested

CT-FFR measurement
invasive FFR

Conditions studied

Coronary Stent Occlusion — all drugs for Coronary Stent Occlusion →

Sponsor

Beijing Hospital

Who can join

Adults 18 to 90, any sex, with Coronary Stent Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CT-FFR(CT-derived flow reserve fraction) usually could not been measured accurately for in-stent lesions due to the serious interference with the metal structs. ISR-Net is a new algorithm in assessing the flow of coronary in-stent stenosis. We compare the CT-FFR value of in-stent lesions with the invasive FFR measured by pressure wire to evaluate the accuracy of ISR-Net algorithm. The research results are of great significance to solve the bottleneck problem of CT-FFR and expand its application scope.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beijing Hospital trials

Trials by the same sponsor.

NCT07523724 — Screening and Management of Adults With Asthma and Allergic Diseases · NA · not yet recruiting
NCT07398430 — Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea · not yet recruiting
NCT07295665 — External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease · not yet recruiting
NCT07143851 — Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases · not yet recruiting
NCT06955819 — GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05131191 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Hospital
Last refreshed: 8 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05131191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing